dc.contributor.author | Aşıkgarip N. | |
dc.contributor.author | Temel E. | |
dc.contributor.author | Hızmalı L. | |
dc.contributor.author | Örnek K. | |
dc.contributor.author | Sezgin F.M. | |
dc.date.accessioned | 2024-03-12T19:35:22Z | |
dc.date.available | 2024-03-12T19:35:22Z | |
dc.date.issued | 2021 | |
dc.identifier.issn | 09273948 | |
dc.identifier.uri | https://doi.org/10.1080/09273948.2020.1853783 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12450/2894 | |
dc.description.abstract | Purpose: To evaluate the longitudinal changes in retinal vessel diameters in patients with coronavirus disease 2019 (COVID-19). Methods: This study included 25 patients with COVID-19 (Group 1) and 25 healthy subjects (Group 2). The diameters of peripapillary temporal and nasal retinal arteries and veins were measured at baseline and at 4 months after remission. Results: The baseline diameters of the inferior temporal vein and the artery were increased in group 1 compared to controls (p = .007 and p = .041, respectively). There was also an increase in the diameters of the inferior and superior nasal veins and arteries in group 1 at baseline (p = .001, p = .019, p = .037, and p = .008, respectively). Retinal vessel diameters decreased after remission in all quadrants in comparison to baseline measurements (all p < .05). Conclusion: Increased retinal vessel diameters were measured in COVID-19 patients during the disease. Measurement of retinal vessel diameters may be a noninvasive method of estimating the vascular risk. © 2020 Taylor & Francis Group, LLC. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Taylor and Francis Ltd. | en_US |
dc.relation.ispartof | Ocular Immunology and Inflammation | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | coronavirus | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | optical coherence tomography | en_US |
dc.subject | retinal vessel diameter | en_US |
dc.subject | phenylephrine | en_US |
dc.subject | tropicamide | en_US |
dc.subject | adolescent | en_US |
dc.subject | adult | en_US |
dc.subject | aged | en_US |
dc.subject | artery diameter | en_US |
dc.subject | Article | en_US |
dc.subject | cardiovascular risk | en_US |
dc.subject | child | en_US |
dc.subject | clinical article | en_US |
dc.subject | controlled study | en_US |
dc.subject | coronavirus disease 2019 | en_US |
dc.subject | female | en_US |
dc.subject | human | en_US |
dc.subject | male | en_US |
dc.subject | neutrophil lymphocyte ratio | en_US |
dc.subject | non invasive procedure | en_US |
dc.subject | optical coherence tomography | en_US |
dc.subject | prospective study | en_US |
dc.subject | remission | en_US |
dc.subject | retina artery | en_US |
dc.subject | retinal vessel diameter | en_US |
dc.subject | risk assessment | en_US |
dc.subject | diagnosis | en_US |
dc.subject | middle aged | en_US |
dc.subject | optic disk | en_US |
dc.subject | pathology | en_US |
dc.subject | procedures | en_US |
dc.subject | retina blood vessel | en_US |
dc.subject | vascularization | en_US |
dc.subject | young adult | en_US |
dc.subject | Adolescent | en_US |
dc.subject | Adult | en_US |
dc.subject | Aged | en_US |
dc.subject | Child | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | Female | en_US |
dc.subject | Humans | en_US |
dc.subject | Male | en_US |
dc.subject | Middle Aged | en_US |
dc.subject | Optic Disk | en_US |
dc.subject | Prospective Studies | en_US |
dc.subject | Retinal Vessels | en_US |
dc.subject | SARS-CoV-2 | en_US |
dc.subject | Tomography, Optical Coherence | en_US |
dc.subject | Young Adult | en_US |
dc.title | Retinal Vessel Diameter Changes in COVID-19 Infected Patients | en_US |
dc.type | article | en_US |
dc.department | Amasya Üniversitesi | en_US |
dc.identifier.volume | 29 | en_US |
dc.identifier.issue | 4 | en_US |
dc.identifier.startpage | 645 | en_US |
dc.identifier.endpage | 651 | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.identifier.scopus | 2-s2.0-85099808588 | en_US |
dc.identifier.doi | 10.1080/09273948.2020.1853783 | |
dc.department-temp | Aşıkgarip, N., Department of Opthalmology, Kırşehir Ahi Evran Training and Research Hospital, Kırşehir, Turkey; Temel, E., Department of Opthalmology, Kırşehir Ahi Evran Training and Research Hospital, Kırşehir, Turkey; Hızmalı, L., Department of Infectious Disease and Clinical Microbiology, Kırşehir Ahi Evran University School of Medicine, Kırşehir, Turkey; Örnek, K., Department of Opthalmology, Kırşehir Ahi Evran University School of Medicine, Kırşehir, Turkey; Sezgin, F.M., Department of Medical Microbiology, Amasya University School of Medicine, Amasya, Turkey | en_US |
dc.authorscopusid | 57221467273 | |
dc.authorscopusid | 57201431292 | |
dc.authorscopusid | 57211351787 | |
dc.authorscopusid | 6603165314 | |
dc.authorscopusid | 56228483300 | |
dc.identifier.pmid | 33497297 | en_US |